- Category: Medical Cannabis News
- Published: Thursday, 23 October 2014 22:42
West Hartford, Conn., October 14, 2014 In advance of the American Epilepsy Societys (AES) Annual Meeting in December, the organization has offered highlights of groundbreaking research being studied at a number of institutions regarding the effectiveness of cannibidiol (CBD) and its derivatives as a viable treatment for people with epilepsy.
The first of three studies (Abstract#2016808) will be presented in full at the Annual Meeting is from Colorado, where much of the nations attention has been captured by issues surrounding cannabis. The physicians and researchers at Childrens Hospital Colorado and the University of Colorado have a unique perspective on CBD given the large number of cases they have treated. In addition to the many children already in their care, these professionals are now caring for many of the patients who have ventured to Colorado in search of cannabis treatment.